苯并恶唑的取代物 | 85902-42-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 中文名称: 苯并恶唑的取代物
• 英文名称: N-(prop-2-yn-1-yl)benzo[d]oxazol-2-amine
• 英文别名: 2-(propargylamino)benzoxazole；N-prop-2-ynyl-1,3-benzoxazol-2-amine
• CAS: 85902-42-7
• 化学式: C₁₀H₈N₂O
• mdl: MFCD16661785
• 分子量: 172.186
• InChiKey: WQKUMFCKLGKQJU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  38.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  苯并恶唑的取代物 在 silver tetrafluoroborate 、 重水 作用下， 生成 3,4-dideuterio-2H-pyrimido[2,1-b][1,3]benzoxazole
  参考文献：
  名称：

  Facile Rearrangements of Alkynylamino Heterocycles with Noble Metal Cations

  摘要：

  A number of 2-(alkynylamino)-substituted heterocycles have been synthesized. These heterocycles rearrange in the presence of silver(I) and gold(I) salts to give novel 2H-pyrimido[2,1-b]benzoxazoles, 2H-pyrimido[2,1-b]benzothiazoles, and a 2H-pyrimido[2,1-b]benzoselenazole. Two of the the 2H-pyrimido[2,1-b]benzoxazoles were isolated in good yield. The kinetics of the silver tetrafluoroborate-catalyzed rearrangements of selected (alkynylamino)benzoxazoles and benzothiazoles have been examined by H-1 NMR in CD3CN. Factors affecting the electron densities of the triple bond and of the nitrogen atom in the heterocycle are important in influencing the rate of rearrangement.

  DOI：

  10.1021/jo952101z
• 作为产物：
  描述：

  2-氯苯并恶唑 、 炔丙胺 在 三乙胺 作用下， 以 乙腈 为溶剂， 反应 4.0h， 以54%的产率得到苯并恶唑的取代物
  参考文献：
  名称：

  Facile Rearrangements of Alkynylamino Heterocycles with Noble Metal Cations

  摘要：

  A number of 2-(alkynylamino)-substituted heterocycles have been synthesized. These heterocycles rearrange in the presence of silver(I) and gold(I) salts to give novel 2H-pyrimido[2,1-b]benzoxazoles, 2H-pyrimido[2,1-b]benzothiazoles, and a 2H-pyrimido[2,1-b]benzoselenazole. Two of the the 2H-pyrimido[2,1-b]benzoxazoles were isolated in good yield. The kinetics of the silver tetrafluoroborate-catalyzed rearrangements of selected (alkynylamino)benzoxazoles and benzothiazoles have been examined by H-1 NMR in CD3CN. Factors affecting the electron densities of the triple bond and of the nitrogen atom in the heterocycle are important in influencing the rate of rearrangement.

  DOI：

  10.1021/jo952101z

文献信息

• [EN] TRICYCLIC PYRAZOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES A BASE DE TYRAZOLES TRICYCLIQUES
  申请人：ABBOTT LAB

  公开号：WO2005095387A1

  公开（公告）日：2005-10-13

  Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明的化合物对抑制蛋白酪氨酸激酶具有用处。还公开了制备这些化合物的方法、含有这些化合物的组合物以及使用这些化合物进行治疗的方法。
• Iodine-Catalyzed Amination of Benzoxazoles: A Metal-Free Route to 2-Aminobenzoxazoles under Mild Conditions
  作者：Manjunath Lamani、Kandikere Ramaiah Prabhu

  DOI：10.1021/jo201402a

  日期：2011.10.7

  route of oxidative amination of benzoxazole by activation of C–H bonds with secondary or primary amines in the presence of catalytic iodine in aqueous tert-butyl hydroperoxide proceeds smoothly at ambient temperature under neat reaction condition to furnish the high yield of the aminated product. This user-friendly method to form C–N bonds produces tertiary butanol and water as the byproduct, which are

  在叔丁基氢过氧化物水溶液中，在催化碘的存在下，在催化反应碘的存在下，通过用仲胺或伯胺活化C–H键与苯胺或伯胺活化，可以轻松实现苯并恶唑氧化胺化的简便金属途径，该条件在环境温度和纯净的反应条件下可顺利进行，以实现高收率。胺化产品。这种形成C–N键的用户友好方法会产生叔丁醇和水作为副产物，对环境无害。通过合成具有治疗活性的苯并恶唑，该方法的应用受到了破坏。
• 신규한 트리아졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 오로라 키나제 관련 약학적 조성물
  申请人：Ewha University - Industry Collaboration Foundation 이화여자대학교 산학협력단(220040083301) BRN ▼110-82-10456

  公开号：KR101723881B1

  公开（公告）日：2017-04-07

  본 발명은 신규한 트리아졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 오로라 키나제 관련 약학적 조성물에 관한 것으로, 본 발명에 따른 신규한 트리아졸 유도체, 이의 광학 이성질체, 또는 이의 약학적으로 허용 가능한 염은, 오로라 키나제로써 나노몰 단위의 우수한 저해활성을 나타내며, 이를 함유하는 약학적 조성물로써 다양한 암 또는 종양의 치료에 유용한 효과가 있다.

  本发明涉及一种新的三唑衍生物，其制备方法及其作为有效成分包含在含有Aurora激酶相关药物的制剂中，根据本发明的新三唑衍生物，其光学异构体或其药学上可接受的盐，通过Aurora激酶表现出优异的纳摩尔单位的抑制活性，并且作为含有该化合物的药学制剂在治疗各种癌症或肿瘤方面具有有益效果。
• Tricyclic pyrazole kinase inhibitors
  申请人：Arnold D. Lee

  公开号：US20060014816A1

  公开（公告）日：2006-01-19

  Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

  本发明的化合物可用于抑制蛋白酪氨酸激酶。还公开了制备该化合物的方法，含有该化合物的组合物，以及使用该化合物的治疗方法。
• Design, synthesis, and evaluation of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives as Aurora kinase inhibitors
  作者：Yunkyung Jeong、Jooyeon Lee、Jae-Sang Ryu

  DOI：10.1016/j.bmc.2016.03.042

  日期：2016.5

  A series of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives were designed, synthesized, and evaluated for the Aurora kinase inhibitory activities. The novel hinge-binder tethered 1,2,3-triazolylsalicylamide scaffold was effectively assembled by Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC). A variety of alkynes with hinge binders were used to search proper structures-binding relationship to the hinge region. The synthesized 1,2,3-triazolylsalicylamide derivatives showed significant Aurora kinase inhibitory activity. In particular, 8a inhibited Aurora A kinase with an IC50 value of 0.284 mu M, whereas 8m inhibited Aurora B kinase with an IC50 value of 0.364 mu M. (C) 2016 Elsevier Ltd. All rights reserved.